Edwards Lifesciences (NYSE:EW) reported quarterly earnings results on February 10, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $0.58, missing the consensus estimate of $0.62 by $0.04 per share. Revenue came in at $1.6B, beating the estimate of $1.5B.
Edwards Lifesciences's stock moved following the earnings release. The stock currently trades at $75.14 with a market capitalization of $49.5B.
